DNA treatment cuts bad cholesterol by nearly 50% without statins
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. GymNews.com curates and briefs the health & wellness stories that matter. Our editorial policy →
Get the daily gym signal